130 related articles for article (PubMed ID: 11073290)
1. Pharmacodynamics and pharmacokinetics of intravenously, orally and rectally administered diacetylmorphine in opioid dependents, a two-patient pilot study within a heroin-assisted treatment program.
Gyr E; Brenneisen R; Bourquin D; Lehmann T; Vonlanthen D; Hug I
Int J Clin Pharmacol Ther; 2000 Oct; 38(10):486-91. PubMed ID: 11073290
[TBL] [Abstract][Full Text] [Related]
2. Arterial and venous pharmacokinetics of intravenous heroin in subjects who are addicted to narcotics.
Rentsch KM; Kullak-Ublick GA; Reichel C; Meier PJ; Fattinger K
Clin Pharmacol Ther; 2001 Sep; 70(3):237-46. PubMed ID: 11557911
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of high doses of intramuscular and oral heroin in narcotic addicts.
Girardin F; Rentsch KM; Schwab MA; Maggiorini M; Pauli-Magnus C; Kullak-Ublick GA; Meier PJ; Fattinger K
Clin Pharmacol Ther; 2003 Oct; 74(4):341-52. PubMed ID: 14534521
[TBL] [Abstract][Full Text] [Related]
4. Oral heroin in opioid-dependent patients: pharmacokinetic comparison of immediate and extended release tablets.
Perger L; Rentsch KM; Kullak-Ublick GA; Verotta D; Fattinger K
Eur J Pharm Sci; 2009 Mar; 36(4-5):421-32. PubMed ID: 19084595
[TBL] [Abstract][Full Text] [Related]
5. Oral diacetylmorphine (heroin) yields greater morphine bioavailability than oral morphine: bioavailability related to dosage and prior opioid exposure.
Halbsguth U; Rentsch KM; Eich-Höchli D; Diterich I; Fattinger K
Br J Clin Pharmacol; 2008 Dec; 66(6):781-91. PubMed ID: 18945270
[TBL] [Abstract][Full Text] [Related]
6. A prospective cohort study on orally administered heroin substitution for severely addicted opioid users.
Frick U; Rehm J; Kovacic S; Ammann J; Uchtenhagen A
Addiction; 2006 Nov; 101(11):1631-9. PubMed ID: 17034443
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of smoked heroin.
Jenkins AJ; Keenan RM; Henningfield JE; Cone EJ
J Anal Toxicol; 1994 Oct; 18(6):317-30. PubMed ID: 7823539
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of high doses of pharmaceutically prepared heroin, by intravenous or by inhalation route in opioid-dependent patients.
Rook EJ; van Ree JM; van den Brink W; Hillebrand MJ; Huitema AD; Hendriks VM; Beijnen JH
Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):86-96. PubMed ID: 16433897
[TBL] [Abstract][Full Text] [Related]
9. Plasma level monitoring of the major metabolites of diacetylmorphine (heroin) by the "chasing the dragon" route in severe heroin addicts.
Dubois N; Demaret I; Ansseau M; Rozet E; Hubert P; Charlier C
Acta Clin Belg; 2013; 68(5):359-67. PubMed ID: 24579243
[TBL] [Abstract][Full Text] [Related]
10. Urinary excretion profiles for total morphine, free morphine, and 6-acetylmorphine following smoked and intravenous heroin.
Smith ML; Shimomura ET; Summers J; Paul BD; Jenkins AJ; Darwin WD; Cone EJ
J Anal Toxicol; 2001 Oct; 25(7):504-14. PubMed ID: 11599592
[TBL] [Abstract][Full Text] [Related]
11. The suitability of oral diacetylmorphine in treatment-refractory patients with heroin dependence: A scoping review.
F Martins ML; Wilthagen EA; Oviedo-Joekes E; Beijnen JH; de Grave N; Uchtenhagen A; Beck T; Van den Brink W; Schinkel AH
Drug Alcohol Depend; 2021 Oct; 227():108984. PubMed ID: 34482044
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of double-blind clinical trials with oral diacetylmorphine: a randomized controlled phase II study in an inpatient setting.
Colom Farran J; Casas M; Pérez de Los Cobos J; Del Río M; Roncero C; Castells X; Valero S; Eiroa-Orosa FJ; Batlle F; Trujols J
Eur Addict Res; 2012; 18(6):279-87. PubMed ID: 22854605
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of orally administered diacetylmorphine substitution treatment.
Frick U; Rehm J; Zullino D; Fernando M; Wiesbeck G; Ammann J; Uchtenhagen A
Eur Addict Res; 2010; 16(3):131-8. PubMed ID: 20424457
[TBL] [Abstract][Full Text] [Related]
14. Safety and feasibility of intranasal heroin-assisted treatment: 4-week preliminary findings from a Swiss multicentre observational study.
Vogel M; Meyer M; Westenberg JN; Kormann A; Simon O; Salim Hassan Fadlelseed R; Kurmann M; Bröer R; Devaud N; Sanwald U; Baumgartner S; Binder H; Strasser J; Krausz RM; Beck T; Dürsteler KM; Falcato L
Harm Reduct J; 2023 Jan; 20(1):2. PubMed ID: 36611162
[TBL] [Abstract][Full Text] [Related]
15. Development of pharmaceutical heroin preparations for medical co-prescription to opioid dependent patients.
Klous MG; Van den Brink W; Van Ree JM; Beijnen JH
Drug Alcohol Depend; 2005 Dec; 80(3):283-95. PubMed ID: 15916865
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic Effects of Intravenous Diacetylmorphine on the Methylation of POMC and NR3C1.
Groh A; Rhein M; Buchholz V; Burkert A; Huber CG; Lang UE; Borgwardt SJ; Heberlein A; Muschler MAN; Hillemacher T; Bleich S; Frieling H; Walter M
Neuropsychobiology; 2017; 75(4):193-199. PubMed ID: 29510398
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetics of heroin and its major metabolites.
Rook EJ; Huitema AD; van den Brink W; van Ree JM; Beijnen JH
Clin Pharmacokinet; 2006; 45(4):401-17. PubMed ID: 16584286
[TBL] [Abstract][Full Text] [Related]
18. Chronic High-Dose Buprenorphine Does Not Block Subjective High from Diacetylmorphine in a Patient in Heroin-Assisted Treatment.
Vogel M; Köck P; Strasser J; Wiesbeck G; Walter M; Dürsteler KM
J Psychoactive Drugs; 2019; 51(4):377-382. PubMed ID: 31046631
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and pharmacodynamics of intranasal "snorted" heroin.
Cone EJ; Holicky BA; Grant TM; Darwin WD; Goldberger BA
J Anal Toxicol; 1993 Oct; 17(6):327-37. PubMed ID: 8271778
[TBL] [Abstract][Full Text] [Related]
20. High levels of morphine-6-glucuronide in street heroin addicts.
Antonilli L; Semeraro F; Suriano C; Signore L; Nencini P
Psychopharmacology (Berl); 2003 Nov; 170(2):200-4. PubMed ID: 12774191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
